|
|
||||||||
1From the Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada; 2Department of Ophthalmology and Visual Sciences, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan; the 3Department of Ophthalmology, University of Maryland, Baltimore, Maryland; and the 4Department of Ophthalmology, State University of New York at Buffalo, Buffalo, New York.
PURPOSE. The gene elongation of very long chain fatty acids-4 (ELOVL4) has been shown to underlie phenotypically heterogeneous forms of autosomal dominant macular degeneration. In this study, the extent of evolutionary conservation and the existence and localization of retinal expression of this gene was investigated across a wide variety of species.
METHODS. Southern blot analysis of genomic DNA and bioinformatic analysis using the human ELOVL4 cDNA and protein sequences, respectively, were performed to identify species in which ELOVL4 orthologues and/or homologues are present. Retinal RNA and protein extracts derived from different species were assessed by Northern hybridization and immunoblot techniques to assess evolutionary conservation of gene expression. Immunohistochemical analysis of tissue sections prepared from various mammalian retinas was performed to determine the distribution of ELOVL4 and homologous proteins within specific retinal cell layers.
RESULTS. The existence of ELOVL4 sequence orthologues and homologues was confirmed by both Southern blot analysis and in silico searches of protein sequence databases. Phylogenetic analysis places ELOVL4 among a large family of known and putative fatty acid elongase proteins. Northern blot analysis revealed the presence of multiple transcripts corresponding to ELOVL4 homologues expressed in the retina of several different mammalian species. Conserved proteins were also detected among retinal extracts of different mammals and were found to localize predominantly to the photoreceptor cell layer within retinal tissue preparations.
CONCLUSIONS. The ELOVL4 gene is highly conserved throughout evolution and is expressed in the photoreceptor cells of the retina in a variety of different species, which suggests that it plays a critical role in retinal cell biology.
This article has been cited by other articles:
![]() |
K. Hashimoto, A. C. Yoshizawa, S. Okuda, K. Kuma, S. Goto, and M. Kanehisa The repertoire of desaturases and elongases reveals fatty acid variations in 56 eukaryotic genomes J. Lipid Res., January 1, 2008; 49(1): 183 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, D. Botolin, J. Xu, B. Christian, E. Mitchell, B. Jayaprakasam, M. Nair, J. M. Peters, J. Busik, L. K. Olson, et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity J. Lipid Res., September 1, 2006; 47(9): 2028 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Raz-Prag, R. Ayyagari, R. N. Fariss, M. N. A. Mandal, V. Vasireddy, S. Majchrzak, A. L. Webber, R. A. Bush, N. Salem Jr, K. Petrukhin, et al. Haploinsufficiency Is Not the Key Mechanism of Pathogenesis in a Heterozygous Elovl4 Knockout Mouse Model of STGD3 Disease. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3603 - 3611. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grayson and R. S. Molday Dominant Negative Mechanism Underlies Autosomal Dominant Stargardt-like Macular Dystrophy Linked to Mutations in ELOVL4 J. Biol. Chem., September 16, 2005; 280(37): 32521 - 32530. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, D. Botolin, B. Christian, J. Busik, J. Xu, and D. B. Jump Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases J. Lipid Res., April 1, 2005; 46(4): 706 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Meyer, H. Kirsch, F. Domergue, A. Abbadi, P. Sperling, J. Bauer, P. Cirpus, T. K. Zank, H. Moreau, T. J. Roscoe, et al. Novel fatty acid elongases and their use for the reconstitution of docosahexaenoic acid biosynthesis J. Lipid Res., October 1, 2004; 45(10): 1899 - 1909. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |